Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
